GlassScriptPhysician profile
Brian A Guillory
NPI 1649242702
$1,197.55
in general payments reported to CMS, 2019-2025
21 companies · $42.69 in 2025
The $42.69 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2020: $80.57 · 2021: $146 · 2022: $326 · 2023: $165 · 2024: $78.40 · 2025: $42.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $286.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $285.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $410.37 | 2019-2023 | |
| Avanos Medical | $109.13 | 2019 | |
| Millicent US INC | $96.55 | 2019-2025 | Femring, Intrarosa |
| Mayne Pharma Commercial LLC | $59.29 | 2022-2025 | |
| Exeltis, USA INC. | $57.28 | 2019-2021 | |
| Pfizer INC. | $56.09 | 2020-2024 | |
| Therapeuticsmd, INC. | $46.86 | 2020-2022 | |
| Astellas Pharma US INC | $46.01 | 2023 | Myrbetriq |
| Mylan Pharmaceuticals INC. | $38.32 | 2022 | |
| Novo Nordisk INC | $34.77 | 2022-2023 | |
| Bausch Health US, LLC | $34.27 | 2022-2023 | Wellbutrin, Aplenzin |
| Roche Diagnostics Corporation | $34.22 | 2019 | |
| Coloplast Corp | $29.86 | 2019 | |
| Urovant Sciences INC | $26.83 | 2022 | |
| Organon LLC | $26.32 | 2022-2024 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $19.57 | 2022 | |
| Becton, Dickinson and Company | $17.65 | 2019 | |
| Amag Pharmaceuticals, INC. | $15.21 | 2019 | |
| Olympus America INC. | $13.43 | 2024 | Hd 3cmos Autoclavable Camera Head |
| Minerva Surgical, INC | $13.37 | 2019 | |
| Meditrina | $12.15 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Guillory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.